NFKB1 and breast carcinoma: In breast cancer models, ANXA1 has been shown to modulate cell adhesion and motility [23] by TGFβ-mediated EMT-like switch [24] and by matrix metalloproteinase-9 regulation via NF-κB [21, 48], but another study found conflicting evidence [49].